Regeneron Pharmaceuticals, Inc.

Report date
3/31/2026
Quarter
2026 Q1
Filed
5/14/2026
Shares
44,800
Value ($000)
34,614
Weight
9.5%
2025 Q4 - 2026 Q1 (2 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).